US0200021014 - Common Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Allstate (ALL) reachead $193.63 at the closing of the latest trading day, reflecting a +0.04% change compared to its last close.
Allstate (ALL) reachead $195.02 at the closing of the latest trading day, reflecting a -0.63% change compared to its last close.
Here is how Credicorp (BAP) and Allstate (ALL) have performed compared to their sector so far this year.
Based on the average brokerage recommendation (ABR), Allstate (ALL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
International and domestic insurers are pushing into the U.S. market for hard-to-protect homes, charging high premiums and enjoying strong profits after some U.S. firms pulled out. This has left greater room for non-domestic players like Hiscox and Munich Re to enter the fray, industry sources say. Recent large U.S. hurricanes Helene and Milton have added to concern about property losses.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Allstate (ALL) concluded the recent trading session at $192.30, signifying a -0.52% move from its prior day's close.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here is how Allstate (ALL) and Credicorp (BAP) have performed compared to their sector so far this year.
Based on the average brokerage recommendation (ABR), Allstate (ALL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Does Allstate (ALL) have what it takes to be a top stock pick for momentum investors? Let's find out.
ALL's strong cash flow generation supports leverage improvement and shareholder returns.
Investors need to pay close attention to Allstate (ALL) stock based on the movements in the options market lately.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The insurance giant has sold off its Chicago headquarters and now wants 25% of its corporate staff to use coworking spaces, a rare move by a big employer.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ALL partners with Thatch, Intuit QuickBooks and Ambetter Health to provide flexible healthcare solutions for customers.
The Progressive, Chubb, The Travelers, The Allstate and Cincinnati Financial have been highlighted in this Industry Outlook article.
Here is how Credicorp (BAP) and Allstate (ALL) have performed compared to their sector so far this year.
According to the average brokerage recommendation (ABR), one should invest in Allstate (ALL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?